Estrogen and interrupted progestin: A new concept for menopausal hormone replacement therapy

American Journal of Obstetrics and Gynecology

Volumn 168, Issue 4, 1993, Pages 1188-1194

  Casper, Robert F ^a,b   Chapdelaine, Alcide ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

breakthrough bleeding; compliance; hormone replacement therapy; Menopause

Indexed keywords

ESTROGEN; GESTAGEN; NORETHISTERONE; PIPERAZINE ESTRONE SULFATE;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; MENOPAUSE; PATIENT COMPLIANCE; PRIORITY JOURNAL; VAGINA BLEEDING;

ADULT; BLOOD PRESSURE; BODY WEIGHT; CLIMACTERIC; DRUG THERAPY, COMBINATION; ENDOMETRIUM; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, SYNTHETIC; ESTRONE; FEMALE; HUMAN; LIPIDS; MENOPAUSE; MENSTRUATION; MIDDLE AGE; PATIENT COMPLIANCE; PILOT PROJECTS; PROGESTATIONAL HORMONES; SUPPORT, NON-U.S. GOV'T;

EID: 0027481270     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9378(93)90367-R     Document Type: Article

References (29)

1. Prevalence and determinants of estrogen replacement therapy in elderly women
2. Cytoplasmic and nuclear estradiol and progesterone receptors in human endometrium
3. Effects of progestins on estradiol receptor levels in human endometrium
4. Rapid recovery of nuclear estrogen receptor and oxytocin receptor in the ovine uterus following progesterone withdrawal
5. Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium
6. Enzymatic modulation of hormonal action at the target tissue
7. Estrogen and progestin regulation of the progesterone receptor concentration in human endometrium
8. Shortterm effects of tamoxifen, medroxyprogesterone acetate, and their combination on receptor kinetics and 17phydroxysteroid dehydrogenase in human endometrium
9. Human endometrial cells in primary tissue culture: modulation of the progesterone receptor level by natural and synthetic estrogens in vitro
10. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency
11. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions
12. Dose response evaluation of cyclic estrogen/gestagen in postmenopausal women: placebo controlled trial of its gynecologic and metabolic actions
13. Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progesterone post-menopausal replacement therapy
14. Efficacy of a continuous estrogen-progestin regimen in the menopausal patient
15. Continuous estrogen/progestin therapy in menopause
16. Amenorrhea and endometrial atrophy following continuous oral estrogen and progestogen therapy in postmenopausal women
17. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy
18. Progesterone-mediated suppression of estradiol receptors in cynomolgus macaque cervix endometrium and oviduct during sequential estradiolprogesterone treatment
19. The prevention and treatment of endometrial pathology in postmenopausal women receiving exogenous estrogens
20. Reduction of plasma high-density lipoprotein-2 cholesterol and increase of postheparin plasma hepatic lipase activity during progestin treatment
21. Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy
22. Use of medroxyprogesterone acetate to prevent menopausal symptoms
23. Progestin regulation of cellular proliferation
24. Menopausal estrogen replacement therapy and breast cancer
25. Evidence of estrogen-receptors in normal human osteoblast-like cells
26. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells
27. Effects of continuous 17(3-estradiol administration on periosteal and corticoendosteal envelope activity in spayed beagles
28. The effect of 17 beta estradiol and progestagen on trabecular bone remodelling in oophorectomized dogs
29. Uncoupling of bone formation and resorption by combined estrogen and progestagen therapy in postmenopausal osteoporosis